Subcutaneous Fat Clinical Trial
— UNIRFFCOfficial title:
Usefulness of Non-invasive Radiofrequency Therapy for Facial Contouring
Verified date | July 2015 |
Source | Kangbuk Samsung Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To evaluate the efficacy of novel noninvasive RF technology for reduction of submental fat.
Status | Completed |
Enrollment | 21 |
Est. completion date | July 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 75 Years |
Eligibility |
Inclusion Criteria: - clinically appreciable localized excess of subcutaneous fat on the submental area - no history of systemic underlying disease Exclusion Criteria: - any infectious or inflammatory skin diseases - keloids - psychiatric patients - systemic underlying disease - who had taken aesthetic procedure on the face, before 6-month - more than 5% weight change were dropped out. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Kangbuk Samsung Hospital | Cutera Inc. |
Franco W, Kothare A, Goldberg DJ. Controlled volumetric heating of subcutaneous adipose tissue using a novel radiofrequency technology. Lasers Surg Med. 2009 Dec;41(10):745-50. doi: 10.1002/lsm.20876. — View Citation
Franco W, Kothare A, Ronan SJ, Grekin RC, McCalmont TH. Hyperthermic injury to adipocyte cells by selective heating of subcutaneous fat with a novel radiofrequency device: feasibility studies. Lasers Surg Med. 2010 Jul;42(5):361-70. doi: 10.1002/lsm.20925. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline in thickness of the submental fat at 6 months | thickness of the submental fat measured by ultrasound | 6 months | |
Primary | Change from Baseline in submental circumference at 6 months | thickness of the submental fat measured by a tape measure | 6 months | |
Secondary | participants' assessment for improvement at 6 months | assessment for improvement by participants | 6 months | |
Secondary | participants' assessment for satisfaction at 6 months | assessment for satisfaction by participants | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04699669 -
A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers
|
Phase 1 | |
Active, not recruiting |
NCT06005441 -
A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.
|
Phase 2 | |
Active, not recruiting |
NCT05736107 -
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
|
Phase 2 | |
Not yet recruiting |
NCT03160976 -
Cryolipolysis on Localized Adiposity
|
N/A | |
Completed |
NCT03871556 -
Diagnostic Ultrasound for Measuring Fat of the Body
|
N/A | |
Completed |
NCT02098811 -
Evaluation of the Safety and Precursors of Efficacy
|
N/A | |
Active, not recruiting |
NCT04553627 -
Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis
|
N/A | |
Completed |
NCT02539043 -
Effects of Ultrasound Cavitation Focused on Located Adiposity
|
N/A | |
Completed |
NCT01842802 -
Clinical Investigation of Non Invasive Fat Reduction
|
N/A | |
Completed |
NCT04698642 -
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat
|
Phase 2 | |
Completed |
NCT02052622 -
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
|
Phase 3 | |
Completed |
NCT04897412 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)
|
Phase 2 | |
Completed |
NCT03682471 -
Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)
|
||
Completed |
NCT05234736 -
A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
|
Phase 2 | |
Completed |
NCT04575467 -
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)
|
Phase 2 |